ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
CM Life Sciences Inc

CM Life Sciences Inc (CMLF)

11,60
0,00
(0,00%)
Fermé 28 Septembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
11,60
Prix Achat
11,70
Prix Vente
11,85
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
11,60
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
25 884 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,31
Bénéfice par action (BPA)
-6,79
Chiffre d'affairess
202,57M
Bénéfice net
-175,77M

À propos de CM Life Sciences Inc

CM Life Sciences Inc is a blank check company. CM Life Sciences Inc is a blank check company.

Secteur
Blank Checks
Industrie
Health Services
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
2020

CMLF Dernières nouvelles

Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company

Sema4 Holdings Corp (“Sema4”) to debut on Nasdaq as a publicly traded company dedicated to transforming healthcare by applying artificial intelligence and machine learning to multidimensional...

Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors

Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of renowned executive Jason Ryan to its...

CM Life Sciences & Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Bus. Combi...

CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, has filed its definitive proxy statement...

Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer

Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of Andrew Kasarskis, PhD, to the newly...

Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement

Updated statement includes Q1 2021 financial results Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences...

AdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and Outcomes

Expanding their investment in precision medicine, AdventHealth is leveraging Sema4’s health intelligence platform to enable a range of clinical and research initiatives AdventHealth and Sema4, a...

Sema4 to Participate in Upcoming Investor Conferences

Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced that members of the Sema4 management team will participate...

Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger

Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition...

CM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Ac...

CM Life Sciences and merger partner Sema4 remain committed to closing transaction as soon as practicable and expect to file proxy statement in next several days CM Life Sciences, Inc...

NorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven Insights

Organizations commit to expanding the impact of genomics and advanced health intelligence among diverse populations to address disparities in personalized health NorthShore University...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
UXINUxin Ltd
US$ 5,145
(81,80%)
46,68M
ONCOOnconetix Inc
US$ 5,92
(76,43%)
34,67M
JFU9F Inc
US$ 2,3101
(76,34%)
2,48M
NANano Labs Ltd
US$ 1,005
(73,31%)
3,34M
CNEYCN Energy Group Inc
US$ 0,9473
(63,36%)
221,87M
ICGIntchains Group Ltd
US$ 4,77
(-43,75%)
2,86M
EDBLEdible Garden AG Inc
US$ 0,288
(-38,09%)
5,79M
DSYBig Tree Cloud Holdings Limited
US$ 2,44
(-28,24%)
416,35k
NVNOenVVeno Medical Corporation
US$ 3,255
(-27,67%)
2,36M
ADTXAditxt Inc
US$ 0,165
(-24,83%)
12,21M
NVDANVIDIA Corporation
US$ 121,40
(-2,13%)
271,05M
XPONExpion360 Inc
US$ 0,0717
(11,34%)
265,7M
CNEYCN Energy Group Inc
US$ 0,9473
(63,36%)
221,88M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,1462
(7,03%)
207,04M
SQQQProShares UltraPro Short QQQ
US$ 7,45
(1,78%)
133,67M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées